The company can now begin the enrollment process for its PROACTIVE-HF 2 clinical trial, which will focus on treating patients with NYHA class II heart failure.
Training AI for use in healthcare requires feeding algorithms patient data, and lots of it. This opens data custodians—typically hospitals—to various points of potential legal exposure.